150 related articles for article (PubMed ID: 10927157)
1. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report.
Brasch R; Turetschek K
Eur J Radiol; 2000 Jun; 34(3):148-55. PubMed ID: 10927157
[TBL] [Abstract][Full Text] [Related]
2. Assessing tumor angiogenesis using macromolecular MR imaging contrast media.
Brasch R; Pham C; Shames D; Roberts T; van Dijke K; van Bruggen N; Mann J; Ostrowitzki S; Melnyk O
J Magn Reson Imaging; 1997; 7(1):68-74. PubMed ID: 9039595
[TBL] [Abstract][Full Text] [Related]
3. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
Cyran CC; Sennino B; Fu Y; Rogut V; Shames DM; Chaopathomkul B; Wendland MF; McDonald DM; Brasch RC; Raatschen HJ
Eur J Radiol; 2012 May; 81(5):891-6. PubMed ID: 21889860
[TBL] [Abstract][Full Text] [Related]
4. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
Daldrup-Link HE; Okuhata Y; Wolfe A; Srivastav S; Øie S; Ferrara N; Cohen RL; Shames DM; Brasch RC
Microcirculation; 2004; 11(5):387-96. PubMed ID: 15280064
[TBL] [Abstract][Full Text] [Related]
5. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.
Turetschek K; Preda A; Floyd E; Shames DM; Novikov V; Roberts TP; Wood JM; Fu Y; Carter WO; Brasch RC
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):448-55. PubMed ID: 12722742
[TBL] [Abstract][Full Text] [Related]
6. Macromolecular MRI contrast agents for imaging tumor angiogenesis.
Barrett T; Kobayashi H; Brechbiel M; Choyke PL
Eur J Radiol; 2006 Dec; 60(3):353-66. PubMed ID: 16930905
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.
Cyran CC; Sennino B; Chaopathomkul B; Fu Y; Rogut V; Shames DM; Wendland MF; McDonald DM; Brasch RC
Invest Radiol; 2008 May; 43(5):298-305. PubMed ID: 18424950
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.
Seshadri M; Bellnier DA; Cheney RT
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1198-207. PubMed ID: 18954713
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
Padhani AR
J Magn Reson Imaging; 2002 Oct; 16(4):407-22. PubMed ID: 12353256
[TBL] [Abstract][Full Text] [Related]
10. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP
J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition.
Preda A; van Vliet M; Krestin GP; Brasch RC; van Dijke CF
Invest Radiol; 2006 Mar; 41(3):325-31. PubMed ID: 16481916
[TBL] [Abstract][Full Text] [Related]
12. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
Pediatr Radiol; 1998 Feb; 28(2):67-78. PubMed ID: 9472047
[TBL] [Abstract][Full Text] [Related]
13. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
14. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model.
Turetschek K; Roberts TP; Floyd E; Preda A; Novikov V; Shames DM; Carter WO; Brasch RC
J Magn Reson Imaging; 2001 Jun; 13(6):882-8. PubMed ID: 11382948
[TBL] [Abstract][Full Text] [Related]
15. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction.
Saeed M; van Dijke CF; Mann JS; Wendland MF; Rosenau W; Higgins CB; Brasch RC
J Magn Reson Imaging; 1998; 8(3):561-7. PubMed ID: 9626869
[TBL] [Abstract][Full Text] [Related]
16. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
[TBL] [Abstract][Full Text] [Related]
17. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.
Cyran CC; Sennino B; Chaopathomkul B; Fu Y; Rogut VS; Shames DM; Wendland MF; McDonald DM; Brasch RC
Eur Radiol; 2009 Jan; 19(1):121-31. PubMed ID: 18665367
[TBL] [Abstract][Full Text] [Related]
19. Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice.
Sennino B; Raatschen HJ; Wendland MF; Fu Y; You WK; Shames DM; McDonald DM; Brasch RC
Magn Reson Med; 2009 Sep; 62(3):616-25. PubMed ID: 19526501
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
